Compulsive eating behaviors in Parkinson’s disease

  • Ingrid de ChazeronEmail author
  • Franck Durif
  • Isabelle Chereau-Boudet
  • Maria Livia Fantini
  • Ana Marques
  • Philippe Derost
  • Berengere Debilly
  • Georges Brousse
  • Yves Boirie
  • Pierre Michel Llorca
Original Article
Part of the following topical collections:
  1. Food and Addiction



Eating disorders are common in Parkinson’s disease (PD) patients and often class in Impulse control disorders, however, little is known about their phenomenology. Specific symptoms and comorbidities were described in a group of PD patients in this preliminary study.


Over a period of 6 months, 51 PD patients who experienced significant changes in eating habits following diagnosis of PD and were interviewed during regularly scheduled follow-up visits. We assessed each patient’s height and weight, impulsivity, psychological distress, current eating disorder symptoms, food addiction, food habits and craving.


Among the PD patients who experienced modified dietary habits following diagnosis, few exhibited binge eating disorders (BED) full criteria (3.9%). However, 21.6% of patients experienced episodes of out-of-control eating with a large quantity of food in short time and 39.2% satisfied food addiction (FA) criteria without binge eating disorder. Food cravings more than once a week were experienced in approximately half of the population including all FA patients. Regarding comorbidities, FA PD patients present impulsive features and anxiety.


This study confirms the existence of FA profile in PD patients. Eating disorders even in PD are complex and have a cross-cutting criteria related to out-of-control eating, FA, and BED. The association of anxiety with PD-related food addiction, contrary to L-dopa equivalent daily dose mean score or the presence of dopamine agonists, underline the complex sustainability of the dopaminergic brainstem support. A study on their detailed prevalence in this population could be helpful to better understand unspecified feeding or eating disorder.

Clinical trial number


Name of the registry

French Committee for the Protection of Persons (CPP) & French National Commission on Computing and Liberty (CNIL).

Level of evidence

Level V, descriptive study.


Eating disorders Food addiction Parkinson’s disease Psychiatry 



Eating disorders


Binge eating disorders


Barratt impulsiveness scale


Body mass index


Compulsive eating


Food addiction


Hospital anxiety and depression scale


Impulse control disorders


Parkinson’s disease


l-DOPA equivalent daily dose


Movement Disorders Society-Unified Parkinson Disease Rating Scale


Night eating syndrome


No food addiction


Questionnaire on Eating and Weight Patterns


Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease


Authors’ contributions

IdC: study design, manuscript preparation and final approval of the version to be submitted. FD: clinical assessment, manuscript preparation and final approval of the version to be submitted. ICB: study design. MLF: clinical assessment. AM: clinical assessment. PD: clinical assessment. BD: clinical assessment. GB: manuscript preparation. YB: manuscript preparation and final approval of the version to be submitted. PML: study design, manuscript preparation and final approval of the version to be submitted. All authors read and approved the final manuscript.


The study was funded by a regional public grant (AOI CHU Clermont-Ferrand 2010). The funder had no role in the writing of the study protocol or in the conductance of the study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the French Ethic Committee (Committees of Protection of Persons South-East 6). It has been qualified by Ethics Committee as an observational study. Pursuant to L.1121-1-1 and R.1121-3 of the French Public Health Code in force at the time of the research, written informed consent from participants to conduct this study was not required.


  1. 1.
    Mestre TA, Strafella AP, Thomsen T, Voon V, Miyasaki J (2013) Diagnosis and treatment of impulse control disorders in patients with movement disorders. Ther Adv Neurol Disord 6:175–188CrossRefGoogle Scholar
  2. 2.
    Schreiber L, Odlaug BL, Grant JE (2011) Impulse control disorders: updated review of clinical characteristics and pharmacological management. Front Psychiatry 2:1CrossRefGoogle Scholar
  3. 3.
    Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30:121–127CrossRefGoogle Scholar
  4. 4.
    Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease. J Neurol Neurosurg Psychiatry 88:317–324CrossRefGoogle Scholar
  5. 5.
    Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL (2011) Evidence that ‘food addiction’ is a valid phenotype of obesity. Appetite 57:711–717. (Epub 2011 Sep 1013) CrossRefGoogle Scholar
  6. 6.
    Alonso-Alonso M, Woods SC, Pelchat M, Grigson PS, Stice E, Farooqi S, Khoo CS, Mattes RD, Beauchamp GK (2015) Food reward system: current perspectives and future research needs. Nutr Rev 73:296–307CrossRefGoogle Scholar
  7. 7.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. APA, WashingtonGoogle Scholar
  8. 8.
    Preti A, Girolamo G, Vilagut G, Alonso J, Graaf R, Bruffaerts R, Demyttenaere K, Pinto-Meza A, Haro JM, Morosini P (2009) The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res 43:1125–1132CrossRefGoogle Scholar
  9. 9.
    Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S (2018) Impulse control disorder in Parkinson’s Disease: a meta-analysis of cognitive, affective, and motivational correlates. Front Neurol 9:654CrossRefGoogle Scholar
  10. 10.
    Thobois S (2006) Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson’s disease: a review of the literature. Clin Ther 28:1–12CrossRefGoogle Scholar
  11. 11.
    Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51:768–774CrossRefGoogle Scholar
  12. 12.
    Yanovski SZ (1993) Binge eating disorder: current knowledge and future directions. Obes Res 1:306–324CrossRefGoogle Scholar
  13. 13.
    Guy-Grand B, Pouillon M, Le Barzic M (1997) Caractérisation des “accés alimentaires impulsifs” chez les sujets obéses”. Cahiers de Nutrition et de Diététique 32:307–312Google Scholar
  14. 14.
    Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64:1089–1096CrossRefGoogle Scholar
  15. 15.
    Wiss DA, Brewerton TD (2017) Incorporating food addiction into disordered eating: the disordered eating food addiction nutrition guide (DEFANG). Eat Weight Disord 22:49–59CrossRefGoogle Scholar
  16. 16.
    Potenza MN, Grilo CM (2014) How relevant is food craving to obesity and its treatment? Front Psychiatry 5:164. (eCollection 02014) CrossRefGoogle Scholar
  17. 17.
    Corwin RL (2011) The face of uncertainty eats. Curr Drug Abuse Rev 4:174–181CrossRefGoogle Scholar
  18. 18.
    Gearhardt AN, White MA, Potenza MN (2011) Binge eating disorder and food addiction. Curr Drug Abuse Rev 4:201–207CrossRefGoogle Scholar
  19. 19.
    Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson’s disease. Ann Neurol 53:676–679CrossRefGoogle Scholar
  20. 20.
    Eichen DM, Lent MR, Goldbacher E, Foster GD: Exploration of “food addiction” in overweight and obese treatment-seeking adults. Appetite 67:22–24., (Epub 2013 Mar 1025., 2013)
  21. 21.
    Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS (2010) Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 16:202–207CrossRefGoogle Scholar
  22. 22.
    Gendreau KE, Potenza MN (2016) Publicity and reports of behavioral addictions associated with dopamine agonists. J Behav Addict 5:140–143CrossRefGoogle Scholar
  23. 23.
    Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update. Lancet Neurol 16:238–250. (Epub 32017 Feb 30015) CrossRefGoogle Scholar
  24. 24.
    Grall-Bronnec M, Victorri-Vigneau C, Donnio Y, Leboucher J, Rousselet M, Thiabaud E, Zreika N, Derkinderen P, Challet-Bouju G (2018) Dopamine agonists and impulse control disorders: a complex association. Drug Saf 41:19–75CrossRefGoogle Scholar
  25. 25.
    Politis M, Wilson H, Wu K, Brooks DJ, Piccini P (2017) Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson’s patients. NeuroImage: Clin 16:455–460CrossRefGoogle Scholar
  26. 26.
    Benton D, Young HA (2016) A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction? Int J Obes Suppl 1:S12–S21CrossRefGoogle Scholar
  27. 27.
    Weintraub D, Mamikonyan E (2019) Impulse control disorders in Parkinson’s disease. Am J Psychiatry 176:5–11CrossRefGoogle Scholar
  28. 28.
    Stoessl AJ, Lehericy S, Strafella AP (2014) Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia. Lancet 384:532–544. (Epub 62014 Jun 60018) CrossRefGoogle Scholar
  29. 29.
    Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864–870CrossRefGoogle Scholar
  30. 30.
    Aracil-Bolanos I, Strafella AP (2016) Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):101–105CrossRefGoogle Scholar
  31. 31.
    Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, Ono Y, Kanba S (2004) Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci 29:134–137Google Scholar
  32. 32.
    Lopez AM, Weintraub D, Claassen DO (2017) Impulse control disorders and related complications of Parkinson’s disease therapy. Semin Neurol 37:186–192CrossRefGoogle Scholar
  33. 33.
    Vriend C (2018) The neurobiology of impulse control disorders in Parkinson’s disease: from neurotransmitters to neural networks. Cell Tissue Res 373:327–336CrossRefGoogle Scholar
  34. 34.
    Kraemmer J, Smith K, Weintraub D, Guillemot V, Nalls MA, Cormier-Dequaire F, Moszer I, Brice A, Singleton AB, Corvol JC (2016) Clinical-genetic model predicts incident impulse control disorders in Parkinson’s disease. J Neurol Neurosurg Psychiatry 87:1106–1111CrossRefGoogle Scholar
  35. 35.
    Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF (2017) Impulsive and compulsive behaviors in Parkinson’s disease: the Norwegian ParkWest Study. J Parkinsons Dis 7:183–191CrossRefGoogle Scholar
  36. 36.
    Nirenberg MJ, Waters C (2006) Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 21:524–529CrossRefGoogle Scholar
  37. 37.
    Borovac JA (2016) Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology. Yale J Biol Med 89:37–47Google Scholar
  38. 38.
    Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson’s disease. Curr Opin Neurol 17:393–398CrossRefGoogle Scholar
  39. 39.
    Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD (2014) Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry 19:1078–1084. (Epub 2014 Sep 1079) CrossRefGoogle Scholar
  40. 40.
    Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595CrossRefGoogle Scholar
  41. 41.
    Ongun N (2018) Does nutritional status affect Parkinson’s Disease features and quality of life? PLoS One 13:e0205100CrossRefGoogle Scholar
  42. 42.
    Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69:986–996CrossRefGoogle Scholar
  43. 43.
    Weintraub D, Papay K, Siderowf A (2013) Screening for impulse control symptoms in patients with de novo Parkinson disease: a case–control study. Neurology 80:176–180CrossRefGoogle Scholar
  44. 44.
    Houeto JL, Magnard R, Dalley JW, Belin D, Carnicella S (2016) Trait impulsivity and anhedonia: two gateways for the development of impulse control disorders in Parkinson’s disease? Front Psychiatry 7:91CrossRefGoogle Scholar
  45. 45.
    Manasse SM, Espel HM, Schumacher LM, Kerrigan SG, Zhang F, Forman EM, Juarascio AS: Does impulsivity predict outcome in treatment for binge eating disorder? A multimodal investigation. Appetite 105:172–179. (Epub 2016 May 1024., 2016)
  46. 46.
    Tahmasian M, Rochhausen L, Maier F, Williamson KL, Drzezga A, Timmermann L, Van Eimeren T, Eggers C (2015) Impulsivity is associated with increased metabolism in the fronto-insular network in Parkinson’s disease. Front Behav Neurosci 9:317CrossRefGoogle Scholar
  47. 47.
    Konttinen H, Mannisto S, Sarlio-Lahteenkorva S, Silventoinen K, Haukkala A (2010) Emotional eating, depressive symptoms and self-reported food consumption. A population-based study. Appetite 54:473–479CrossRefGoogle Scholar
  48. 48.
    Kawada T, Suzuki S (2011) Depressive state, aging, and prevalence of snacking: a preliminary study. Psychogeriatrics 11:247–248CrossRefGoogle Scholar
  49. 49.
    Miwa H, Kondo T: Alteration of eating behaviors in patients with Parkinson’s disease: possibly overlooked? Neurocase 14:480–484, 2008CrossRefGoogle Scholar
  50. 50.
    Fineberg NA, Apergis-Schoute AM, Vaghi MM, Banca P, Gillan CM, Voon V, Chamberlain SR, Cinosi E, Reid J, Shahper S, Bullmore ET, Sahakian BJ, Robbins TW (2018) Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment. Int J Neuropsychopharmacol 21:42–58CrossRefGoogle Scholar
  51. 51.
    Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Andrews H, Waters C, Fahn S, Cote L, Frucht S, Ford B, Alcalay RN, Ross B, Orbe Reilly M, Rezak M, Novak K, Friedman JH, Pfeiffer RD, Marsh L, Hiner B, Merle D, Ottman R, Clark LN, Marder K (2011) The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism Relat Disord 17:740–744. CrossRefGoogle Scholar
  52. 52.
    Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM (2016) Impulsive-compulsive behaviors in parkin-associated Parkinson disease. Neurology 87:1436–1441CrossRefGoogle Scholar
  53. 53.
    Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, Strafella AP (2015) Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease. Mov Disord 30:141–149CrossRefGoogle Scholar
  54. 54.
    Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson’s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32:1264–1310CrossRefGoogle Scholar
  55. 55.
    Schulte EM, Grilo CM, Gearhardt AN (2016) Shared and unique mechanisms underlying binge eating disorder and addictive disorders. Clin Psychol Rev 44:125–139CrossRefGoogle Scholar
  56. 56.
    Davis C, Loxton NJ, Levitan RD, Kaplan AS, Carter JC, Kennedy JL (2013) ‘Food addiction’ and its association with a dopaminergic multilocus genetic profile. Physiol Behav 118:63–69CrossRefGoogle Scholar
  57. 57.
    Rose N, Koperski S, Golomb BA (2010) Mood food: chocolate and depressive symptoms in a cross-sectional analysis. Arch Intern Med 170:699–703CrossRefGoogle Scholar
  58. 58.
    Gordon EL, Ariel-Donges AH, Bauman V, Merlo LJ (2018) What is the evidence for “Food Addiction?”. A systematic review. Nutrients 10(4):477. Google Scholar
  59. 59.
    Schulte EM, Avena NM, Gearhardt AN (2015) Which foods may be addictive? The roles of processing, fat content, and glycemic load. PLoS One 10(2):e0117959. (eCollection 0112015) CrossRefGoogle Scholar
  60. 60.
    Morton GJ, Meek TH, Schwartz MW (2014) Neurobiology of food intake in health and disease. Nature reviews. Neuroscience 15:367–378Google Scholar
  61. 61.
    Calvez J, Timofeeva E (2016) Behavioral and hormonal responses to stress in binge-like eating prone female rats. Physiol Behav 157:28–38CrossRefGoogle Scholar
  62. 62.
    Pedram P, Sun G (2014) Hormonal and dietary characteristics in obese human subjects with and without food addiction. Nutrients 7:223–238. CrossRefGoogle Scholar
  63. 63.
    Avena NM, Bocarsly ME (2012) Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa. Neuropharmacology 63:87–96CrossRefGoogle Scholar
  64. 64.
    Kurian P, Obisesan TO, Craddock TJA (2017) Oxidative species-induced excitonic transport in tubulin aromatic networks: potential implications for neurodegenerative disease. J Photochem Photobiol B 175:109–124CrossRefGoogle Scholar
  65. 65.
    Gearhardt AN, Corbin WR, Brownell KD (2016) Development of the Yale Food Addiction Scale Version 2.0. Psychol Addict Behav 30:113–121. CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ingrid de Chazeron
    • 1
    Email author
  • Franck Durif
    • 2
  • Isabelle Chereau-Boudet
    • 1
  • Maria Livia Fantini
    • 2
  • Ana Marques
    • 2
  • Philippe Derost
    • 2
  • Berengere Debilly
    • 2
  • Georges Brousse
    • 1
  • Yves Boirie
    • 3
  • Pierre Michel Llorca
    • 1
  1. 1.Service de Psychiatrie BCHU Clermont-Ferrand, EA7280, Université Clermont AuvergneClermont-FerrandFrance
  2. 2.Service de neurologie ACHU Clermont-Ferrand, EA7280, Université Clermont AuvergneClermont-FerrandFrance
  3. 3.Service de nutrition cliniqueCHU Clermont-Ferrand, INRA, UMR 1019, UNH, CRNH AuvergneClermont-FerrandFrance

Personalised recommendations